How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

28,368 results for

Topical Corticosteroid

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Shoulder Corticosteroid Injection in Diabetic Patients

information Study Type : Observational Actual Enrollment : 20 participants Observational Model: Cohort Time Perspective: Prospective Official Title: Efficacy and Safety of Subacromial Corticosteroid Injection in Type-2 Diabetic Actual Study Start Date : March 2013 Actual Primary Completion Date : March 2014 Actual Study Completion Date : September 30, 2014 Resource links provided by the National Library of Medicine related topics: related topics: Groups and Cohorts Go to Outcome Measures Go to Primary (...) Shoulder Corticosteroid Injection in Diabetic Patients Shoulder Corticosteroid Injection in Diabetic Patients - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Shoulder Corticosteroid Injection in Diabetic

2018 Clinical Trials

142. Corticosteroids/β2-agonists in Hair in Asthmatic Patients (CorticHair)

Corticosteroids/β2-agonists in Hair in Asthmatic Patients (CorticHair) Corticosteroids/β2-agonists in Hair in Asthmatic Patients (CorticHair) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Corticosteroids (...) -Randomized Intervention Model: Parallel Assignment Intervention Model Description: Half of the patients is enrolled in each group according to the individual dose decided by the clinician in charge as the optimal dose to treat the disease. The optimized dose to treat the disease is decided independently of the participation to the study. Masking: None (Open Label) Primary Purpose: Other Official Title: Therapeutic Drug Monitoring of Corticosteroids/β2-agonists in Hair in Asthmatic Patients: an Open-label

2018 Clinical Trials

143. Toward effective prescription of inhaled corticosteroids in chronic airway disease Full Text available with Trip Pro

Toward effective prescription of inhaled corticosteroids in chronic airway disease 30425471 2019 03 07 2019 03 07 1178-2005 13 2018 International journal of chronic obstructive pulmonary disease Int J Chron Obstruct Pulmon Dis Toward effective prescription of inhaled corticosteroids in chronic airway disease. 3419-3424 10.2147/COPD.S174216 Diamant Zuzana Z Department of Respiratory Medicine and Allergology, Lund University, Lund, Sweden. Department of Clinical Pharmacy & Pharmacology University (...) , Hampshire, UK, richard.russell@ndm.ox.ac.uk. eng Editorial 2018 10 18 New Zealand Int J Chron Obstruct Pulmon Dis 101273481 1176-9106 0 Glucocorticoids 0 Respiratory System Agents IM Administration, Inhalation Asthma drug therapy Glucocorticoids pharmacology Humans Inappropriate Prescribing prevention & control Medication Therapy Management standards trends Practice Guidelines as Topic Precision Medicine Pulmonary Disease, Chronic Obstructive drug therapy Respiratory System Agents pharmacology Treatment

2018 International journal of chronic obstructive pulmonary disease

144. Hidradenitis suppurativa with SAPHO syndrome maintained effectively with adalimumab, methotrexate, and intralesional corticosteroid injections Full Text available with Trip Pro

of a 40-year-old man with hidradenitis suppurativa and synovitis, acne, pustulosis, hyperostosis, osteitis syndrome, and reviews relevant literature. Initial oral and topical antibiotics had little effect. Intralesional corticosteroid injections were effective for localized inflammatory lesions but insufficient for hidradenitis suppurativa control. Adalimumab initiation and local excision of a persistent HS lesion led to stabilization. Adalimumab provided dramatic back pain improvement. Synovitis (...) Hidradenitis suppurativa with SAPHO syndrome maintained effectively with adalimumab, methotrexate, and intralesional corticosteroid injections Hidradenitis suppurativa and synovitis, acne, pustulosis, hyperostosis, osteitis syndrome are chronic, debilitating diseases involving apocrine gland-bearing skin inflammation and bone inflammation, respectively. Although both often present with multiple comorbidities, single patient co-presentation is rare.This study reports the 8-year treatment course

2018 SAGE Open Medical Case Reports

145. Pharmacology of Corticosteroids for Diabetic Macular Edema. Full Text available with Trip Pro

Pharmacology of Corticosteroids for Diabetic Macular Edema. Corticosteroids remain the mainstay of treatment for inflammatory diseases almost 80 years after their first clinical use. Topical ophthalmic formulations of corticosteroids have been available to treat disease of the anterior segment of the eye, but the approval of corticosteroids to treat vitreoretinal diseases, including vein occlusion, diabetic macular edema, and uveitis, has occurred only recently. Although most diseases respond (...) to corticosteroid therapy, some patients are resistant to this therapy and side effects, including cataract and elevated intraocular pressure, can limit their use. The purpose of this review is to detail the basic science of corticosteroids focusing on differences in potency, drug delivery, pharmacokinetics, and gene activation, and how these differences affect safety and efficacy in the treatment of diabetic macular edema.A review was conducted of basic science and pharmacology of the corticosteroids used

2018 Investigative Ophthalmology & Visual Science

146. Patients' preferences for different corticosteroid vehicles are highly variable. (Abstract)

Patients' preferences for different corticosteroid vehicles are highly variable. Topical corticosteroids, available in an array of vehicles are used to control a variety of inflammatory skin diseases. Patients' preferences for different vehicles may affect their willingness to use treatment. We assess corticosteroid vehicle preference and potential impact of topical characteristics on adherence and quality of life in patients with psoriasis.Subjects with psoriasis were recruited from Wake (...) highly variable. Regarding determinants of adherence, patients' perception of absorption of the medication was ranked as 'quite important/extremely important' by 85% of total subjects. A majority of patients rated medication side effects as 'quite important/extremely important' when asked to consider topical characteristics' effect on quality of life.There was wide variation in patient preference for topical medication vehicles used for treating psoriasis. Several vehicle characteristics were

2018 Journal of Dermatological Treatment

147. Corticosteroid nasal irrigations are more effective than simple sprays in a randomized double-blinded placebo-controlled trial for chronic rhinosinusitis after sinus surgery. (Abstract)

Corticosteroid nasal irrigations are more effective than simple sprays in a randomized double-blinded placebo-controlled trial for chronic rhinosinusitis after sinus surgery. Persistent mucosal inflammation in patients with chronic rhinosinusitis (CRS) often results in ongoing symptoms, recurrence of polypoid mucosa, infective exacerbations, and further systemic medication despite surgical intervention. Debate exists as to the most effective topical therapy in CRS.The objective was to determine (...) if corticosteroid delivered via a nasal irrigation or via a simple nasal spray would be more effective in controlling the symptoms and signs of CRS. A double-blind placebo-controlled randomized trial over 12 months was performed between 3 tertiary rhinologic clinics. After sinus surgery, all patients performed a nasal irrigation followed by a nasal spray once a day for 12 months. Groups were defined by corticosteroid (2 mg mometasone) delivered by either spray or irrigation. The primary outcomes were patient

2018 International forum of allergy & rhinology Controlled trial quality: predicted high

148. Continuous Glucose Monitoring of Late Preterm Birth After Corticosteroids

Continuous Glucose Monitoring of Late Preterm Birth After Corticosteroids Continuous Glucose Monitoring of Late Preterm Birth After Corticosteroids - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Continuous (...) Glucose Monitoring of Late Preterm Birth After Corticosteroids The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03738293 Recruitment Status : Not yet recruiting First Posted : November 12, 2018 Last Update Posted : November

2018 Clinical Trials

149. Corticosteroids and Myocardial Injury in CAP (COLOSSEUM TRIAL)

allocation until the end of their involvement in the trial and after the completion of the trial Primary Purpose: Treatment Official Title: Effect of Corticosteroids On MyocardiaL Injury Among Patients Hospitalized for Community-AcquirEd PneUMonia - COLOSSEUM TRIAL Estimated Study Start Date : January 10, 2019 Estimated Primary Completion Date : May 16, 2020 Estimated Study Completion Date : September 1, 2022 Resource links provided by the National Library of Medicine related topics: available for: Arms (...) : corticosteroids Additional relevant MeSH terms: Layout table for MeSH terms Pneumonia Lung Diseases Respiratory Tract Diseases Respiratory Tract Infections Pharmaceutical Solutions Methylprednisolone Methylprednisolone Acetate Methylprednisolone Hemisuccinate Prednisolone Prednisolone acetate Prednisolone hemisuccinate Prednisolone phosphate Anti-Inflammatory Agents Antiemetics Autonomic Agents Peripheral Nervous System Agents Physiological Effects of Drugs Gastrointestinal Agents Glucocorticoids Hormones

2018 Clinical Trials

150. Treatment of Hypertrophic Scars Using Laser-Assisted Corticosteroid Versus Laser-Assisted 5-Fluorouracil Delivery. (Abstract)

topical triamcinolone acetonide (20 mg/mL) or topical 5-fluorouracil (50 mg/mL).Three sessions of laser-assisted triamcinolone acetonide and 5-fluorouracil delivery both produced reductions in overall scar area. When compared with one another, there were no statistically significant differences in area reduction between the 2 modalities (p = .603). However, scars treated with 5-fluorouracil were not associated with side effects seen with corticosteroid therapy, such as dermal atrophy or telangiectasia (...) Treatment of Hypertrophic Scars Using Laser-Assisted Corticosteroid Versus Laser-Assisted 5-Fluorouracil Delivery. As the mortality of individuals suffering severe cutaneous injuries decreases, there is an increased need to improve the methods by which physicians treat the resultant scars. Fractional lasers, which create zones of ablation at variable depths, provide a powerful tool in the management of scar complications and deformities. After disruption of the normal skin barrier, these zones

2018 Dermatologic Surgery

151. Efficacy of Dehydrated Cell and Protein Concentrate Versus Corticosteroid

Efficacy of Dehydrated Cell and Protein Concentrate Versus Corticosteroid Efficacy of Dehydrated Cell and Protein Concentrate Versus Corticosteroid - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Efficacy (...) of Dehydrated Cell and Protein Concentrate Versus Corticosteroid The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03710005 Recruitment Status : Recruiting First Posted : October 17, 2018 Last Update Posted : November 9, 2018 See

2018 Clinical Trials

152. Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody-Drug Conjugate Mirvetuximab Soravtansine. Full Text available with Trip Pro

drop use resulted in fewer dose reductions (5% vs. 15%) and none discontinued due to ocular AEs.Preclinical modeling was predictive of the corneal-related symptoms seen in some patients dosed with mirvetuximab soravtansine. Primary prophylactic use of topical corticosteroid eye drops resulted in a trend toward symptomatic improvement and a reduction in ocular AE-related dose modifications in patients treated with mirvetuximab soravtansine.©2018 American Association for Cancer Research. (...) Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody-Drug Conjugate Mirvetuximab Soravtansine. Reversible, low-grade ocular adverse events (AE) are associated with administration of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeted antibody-drug conjugate undergoing phase III clinical evaluation in platinum-resistant ovarian cancer. This study investigated the underlying mechanisms of ocular toxicity

2018 Clinical Cancer Research

153. Evaluate the Therapeutic Effect of Inhaled Corticosteroid in Asthmatic Children

the Therapeutic Effect of Inhaled Corticosteroid in Asthmatic Children Actual Study Start Date : October 22, 2016 Estimated Primary Completion Date : December 31, 2019 Estimated Study Completion Date : December 31, 2019 Resource links provided by the National Library of Medicine related topics: available for: Groups and Cohorts Go to Group/Cohort Intervention/treatment NTUH National Taiwan University Hospital, all participants receive Duasma (budesonide, 200mcg/puff) Drug: Budesonide/Cisclesonide One arm (...) Evaluate the Therapeutic Effect of Inhaled Corticosteroid in Asthmatic Children Evaluate the Therapeutic Effect of Inhaled Corticosteroid in Asthmatic Children - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more

2018 Clinical Trials

154. Safety of Itacitinib in Combination With Corticosteroids for Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects

of Itacitinib in Combination With Corticosteroids for the Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects Actual Study Start Date : March 20, 2018 Estimated Primary Completion Date : August 2019 Estimated Study Completion Date : August 2019 Resource links provided by the National Library of Medicine related topics: resources: Arms and Interventions Go to Arm Intervention/treatment Experimental: Itacitinib + corticosteroids Itacitinib administered in combination (...) Safety of Itacitinib in Combination With Corticosteroids for Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects Safety of Itacitinib in Combination With Corticosteroids for Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save

2018 Clinical Trials

155. Corticosteroid vs. Amniotic Fluid Injections in Patients With Trigger Finger

Corticosteroid vs. Amniotic Fluid Injections in Patients With Trigger Finger Corticosteroid vs. Amniotic Fluid Injections in Patients With Trigger Finger - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Corticosteroid vs. Amniotic Fluid Injections in Patients With Trigger Finger The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03583151 Recruitment Status : Enrolling by invitation First Posted : July 11, 2018 Last Update Posted : July 11, 2018 Sponsor: J&M Shuler Collaborator: Vivex Biomedical Information

2018 Clinical Trials

156. GRAVITAS-309: Itacitinib or Placebo in Combination With Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

Library of Medicine related topics: resources: Arms and Interventions Go to Arm Intervention/treatment Experimental: Itacitinib + corticosteroids Itacitinib administered in combination with corticosteroids. Drug: Itacitinib In Part 1 participants will receive itacitinib administered orally once daily at the protocol-defined dose according to cohort enrollment. In Part 2, participants will receive the recommended dose from Part 1. Other Name: INCB039110 Drug: Methylprednisolone Administered in Parts 1 (...) : Yes Studies a U.S. FDA-regulated Device Product: No Keywords provided by Incyte Corporation: Graft-versus-host-disease itacitinib Janus kinase inhibitor corticosteroids Additional relevant MeSH terms: Layout table for MeSH terms Graft vs Host Disease Immune System Diseases Prednisone Methylprednisolone Methylprednisolone Acetate Methylprednisolone Hemisuccinate Prednisolone Prednisolone acetate Prednisolone hemisuccinate Prednisolone phosphate Anti-Inflammatory Agents Glucocorticoids Hormones

2018 Clinical Trials

157. Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma

With Severe Eosinophilic Asthma on High Dose Inhaled Corticosteroid Plus Long-acting β2 Agonist and Chronic Oral Corticosteroid Therapy Actual Study Start Date : August 1, 2018 Estimated Primary Completion Date : October 30, 2020 Estimated Study Completion Date : October 30, 2020 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: Benralizumab Benralizumab subcutaneous injection Biological (...) Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma Study to Evaluate Efficacy and Safety of Benralizumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached

2018 Clinical Trials

158. Efficacy of Oral Corticosteroid Therapy in Recurrent Paralyzes After Thyroidectomy

: Double (Participant, Investigator) Primary Purpose: Treatment Official Title: Efficacy of Oral Corticosteroid Therapy in Recurrent Paralyzes After Thyroidectomy Actual Study Start Date : September 11, 2018 Estimated Primary Completion Date : January 1, 2020 Estimated Study Completion Date : January 1, 2020 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: Corticoids Drug: Corticoids Patients will receive (...) is to evaluate the efficacy of oral corticosteroid therapy in remobilization of vocal cords at seven days in patients with unilateral recurrent paralysis after thyroidectomy. Condition or disease Intervention/treatment Phase Recurrent Paralysis of Vocal Cords Drug: Corticoids Other: Placebo Phase 3 Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Estimated Enrollment : 156 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking

2018 Clinical Trials

159. COrticosteroids in acUte uRticAria in emerGency dEpartment

: Treatment Official Title: COrticosteroids in acUte uRticAria in emerGency dEpartment Estimated Study Start Date : December 1, 2018 Estimated Primary Completion Date : November 15, 2020 Estimated Study Completion Date : January 15, 2021 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: Antihistamines + placebo of cortancyl - In emergency department : Levocetirizine 5 mg orally. Renewable once (...) COrticosteroids in acUte uRticAria in emerGency dEpartment COrticosteroids in acUte uRticAria in emerGency dEpartment - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. COrticosteroids in acUte uRticAria

2018 Clinical Trials

160. Systemic Corticosteroids Avoidance Study in Severe Asthma Patients

: Treatment Official Title: A 52-week, Multicenter, Randomized, Double-blind, Double-dummy, Parallel-group, Placebo-controlled Study of Fevipiprant Once Daily Plus Standard-of-care (SoC) for Reduction of Systemic Corticosteroids (Oral and Parenteral) Use in Patients With Severe Asthma Estimated Study Start Date : December 7, 2018 Estimated Primary Completion Date : May 27, 2021 Estimated Study Completion Date : May 27, 2021 Resource links provided by the National Library of Medicine related topics: Arms (...) Systemic Corticosteroids Avoidance Study in Severe Asthma Patients Systemic Corticosteroids Avoidance Study in Severe Asthma Patients - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Systemic Corticosteroids

2018 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>